| Literature DB >> 34556962 |
Madhava Sai Sivapuram1, Vinod Srivastava2, Navneet Kaur3, Akshay Anand4,5,6, Raghuram Nagarathna7, Suchitra Patil7, Saranga Biman7, Ishwar Chander8, Saras Jyoti9, Hongasandra Ramarao Nagendra7.
Abstract
BACKGROUND: Type 2 diabetes needs a better understanding of etiological factors and management strategies based on lifestyle and constitutional factors, given its high association rate with many cardiovascular, neurological disorders, and COVID-19 infection.Entities:
Keywords: Diabetes mellitus (DM); Diabetes-specific integrated Yoga lifestyle Protocol (DYP); Glycosylated hemoglobin (A 1 c); Lipid profile; Prakriti
Year: 2021 PMID: 34556962 PMCID: PMC8454998 DOI: 10.1177/09727531211000040
Source DB: PubMed Journal: Ann Neurosci ISSN: 0972-7531
Figure 1.The Study Profile of Chandigarh and Panchkula
Diabetes-Specific Integrated Yoga Lifestyle Protocol (DYP)
| 1 | Opening prayer: | 2 |
| 2 | Loosening exercises (preparatory | 6 |
| 3 | 9 | |
| 4 | 15 | |
| 5 | 3 | |
| 6 | 9 | |
| 7 | Meditation (for stress relief, deep relaxation, and silencing of mind) cyclic meditation | 15 |
| 8 | Resolve (I am completely healthy) | 1 |
| 9 | Closing prayer: | 1 |
| Total duration | 60 |
The Effect of Each Asana or Practice/Procedure
| 1. | Subcutaneous tissue fat is removed because of extensive muscle workouts; harmonizing effect at | ||
| 2. | Standing position | Limbs, buttocks, and abdominal region fat reduction; | |
| Sitting position | Abdominal region fat reduction; | ||
| Supine position | Abdominal region fat reduction; | ||
| Prone position | Fat reduction at buttock and shoulder level; | ||
| 3. | Developing deep internal awareness; | ||
| 4. | Relaxation | Alertful rest through stress reduction (sympathetic activity decreased). | |
| 5. | Regulation of breath; removes the random agitations in | ||
| 6. | Meditation | Mental alertness increases and so does physiological relaxation with the reduced heart rate. | |
Questionnaire for (Ayurveda Personality) Analysis
| 1 | Height | Short | Normal | Tall | |||
| 2 | Weight | Underweight | Normal | Overweight | |||
| 3 | Complexion | Brown | Wheatish | Fair | |||
| 4 | Gait | Fast | Normal | Slow | |||
| 5 | Voice | Harsh | Thin | Heavy | |||
| 6 | Hair color | Grey | Very black | Normal | |||
| 7 | Iris color | Blue/Dark brown | Black | Brown | |||
| 8 | Activities | Fast | Normal | Slow | |||
| 9 | Personal grooming | Unmanageable | Normal | Manageable | |||
| 10 | Body parts | Short | Normal | Big | |||
| 1 | Skin | Dry | Normal | Oily/Moist | |||
| 2 | Pulse | Uncertain/Fast | Normal | Normal/Slow | |||
| 3 | Hair | Dry | Wheatish | Oily/Moist | |||
| 4 | Muscle | Thin | Normal | Fat | |||
| 5 | Nails | Dry | Thin | Oily/Moist | |||
| 6 | Tendon reflex | Fast | Very black | Slow | |||
| 7 | Pain on pressing | Maximum | Black | Low | |||
| 8 | Tongue | Dry/Pale | Normal | Moist/Thick | |||
| 9 | Bones | Thin, fragile | Normal | Thick and strong | |||
| 10 | Pulse | Leech, snake | Normal | Pigeon/Swan | |||
| 1 | Favorite juice | Sweet | Salty | Bitter | |||
| 2 | Sleep | Less | Normal | Over | |||
| 3 | Favorite season | Rainy | Winter | Summer | |||
| 4 | Favorite color | Brown or grey | Red and dark | White or light | |||
| 5 | Dreams | Vacuum places, sky | Fire | Hilly areas | |||
| 6 | Voice (quality of speech) | Dry | Thin and sweet | Heavy and sweet | |||
| 7 | Appetite | Irregular | Excessive | Moderate | |||
| 8 | Temperament | Firm in decisions | Angry in decisions | Constant in decisions | |||
| 9 | Feeling of pain | Highly tolerant | Moderately tolerant | Low tolerance | |||
| 10 | Power | Less | Normal | High | |||
Note: Scoring key: yes 1; no 0. Total possible score 10 × 3 = 30. Vata personality ≥20 in vata total score; pitta personality ≥ 20 in pitta total score; kapha personality ≥ 20 in kapha total score.
Result: No. of diabetic subjects: pitta = 20; pitta-kapha = 2; vata-pitta = 1.
Baseline Characteristics of Both the Treatment and the Control Subjects
| Sample size ( | 50 | 31 |
| Age (years) M ± (SD) | 58.86 ± 24.73 | 53.31 ± 7.71 |
| Height (cm) M ± (SD) | 67.98 ± 11.51 | 70.40 ± 13.55 |
| Weight (kg) M ± (SD) | 26.51 ± 4.18 | 28.51 ± 5.11 |
| BMI M ± (SD) | 97.42 ± 9.14 | 99.78 ± 11.34 |
| Hip circumference (cm) M ± (SD) | 96.26 ± 10.60 | 97.51 ± 11.55 |
| Waist circumference (cm) M ± (SD) | 67.98 ± 11.51 | 70.40 ± 13.55 |
The Pre and Postbiochemical Parameters in the Interventional Group and the Control Group
| P | |||||||||
| P | |||||||||
| Fasting blood glucose (FBG) | 50 | 167.46 ± 58.22 | 169.01 ± 84.6 | <0.02 | 31 | 176.51 ± 64.09 | 173.00 ± 73.39 | 0.25 | 0.80 |
| Postprandial blood glucose (PPBG) | 28 | 259.14 ± 92.46 | 231.53 ± 128.13 | <0.01 | 28 | 259.25 ± 96.89 | 224.50 ± 111.37 | <0.01 | 0.96 |
| A1c | 50 | 8.49 ± 1.94 | 7.97 ± 2.20 | <0.01 | 31 | 8.60 ± 1.84 | 10.22 ± 1.66 | 0.49 | 0.03 |
| Mean plasma glucose (MPG) | 50 | 197.02 ± 55.81 | 182.10 ± 63.17 | <0.01 | 31 | 200.26 ± 52.87 | 186.69 ± 61.12 | <0.01 | 0.13 |
| Total cholesterol (TC) | 50 | 175.16 ± 47.88 | 186.02 ± 37.80 | <0.01 | 31 | 181.22 ± 41.05 | 176.83 ± 47.88 | <0.01 | 0.40 |
| Triglycerides (TG) | 50 | 169.68 ± 109.38 | 192.92 ± 128.23 | <0.01 | 31 | 196.19 ± 99.62 | 212.77 ± 100.35 | <0.01 | 0.60 |
| High-density lipoprotein (HDL) | 49 | 43.83 ± 9.35 | 45.36 ± 10.94 | <0.01 | 31 | 41.64 ± 10.82 | 42.16 ± 11.69 | <0.01 | 0.30 |
| Low-density lipoprotein (LDL) | 49 | 99.91 ± 33.60 | 102.10 ± 30.53 | <0.01 | 31 | 98.51 ± 38.07 | 92.16 ± 41.22 | <0.01 | 0.26 |
| Very-low-density lipoprotein (VLDL) | 46 | 31.15 ± 15.41 | 34.40 ± 17.58 | <0.01 | 17 | 31.82 ± 9.67 | 36.9 ± 13.80 | <0.04 | 0.25 |
| Chol/HDL ratio | 50 | 4.08 ± 1.54 | 4.30 ± 1.42 | <0.01 | 31 | 4.52 ± 1.13 | 4.32 ± 1.01 | <0.01 | 0.13 |
| HDL/LDL ratio | 50 | 2.30 ± 0.95 | 2.33 ± 0.83 | <0.01 | 31 | 2.49 ± 0.89 | 2.19 ± 0.78 | <0.01 | 0.12 |
Tridosha Characterization in the Subjects
| Prediabeticsubjects | 9 | 3 | 0 | 12 | |
| 75.0% | 25.0% | 0.0% | |||
| Diabetic subjects | 20 | 2 | 1 | 23 | |
| 87.0% | 8.7% | 4.3% | |||